TheEdgeResearch
Home / Stocks / THQ

Abrdn Healthcare Opportunities Fund (THQ)

NYSE Financial Services Asset Management
$19.54 ▲ +0.00%
Market Cap
$809.7M
Sector
Financial Services
Industry
Asset Management
Beta
0.88
52-Wk Range
15.71-20.39
CEO
Daniel R. Omstead
Country
US
Currency
USD

Abrdn Healthcare Opportunities Fund operates in the Asset Management industry of the Financial Services sector, headquartered in Philadelphia, PA, US. The stock last traded at $19.54, up 0.00% on the session, giving a market capitalisation of $809.7M. On trailing twelve-month figures it carries a trailing P/E of -27.91, a net margin of -93.7%. Its beta of 0.88 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
-27.91
Price / Sales
26.16
Price / Book
1.12
EV / EBITDA
-34.65
Gross margin
66.6%
Operating margin
-96.5%
Net margin
-93.7%
Return on equity
Debt / equity
0.31
Current ratio
0.06
Dividend yield
11.1%
Payout ratio
-304.1%
Company profile
Exchange
New York Stock Exchange
Employees
IPO date
2014-07-29
Headquarters
Philadelphia, PA, US
About Abrdn Healthcare Opportunities Fund

Managed by Tekla Capital Management LLC, the Tekla Healthcare Opportunities Fund operates as a closed-end, balanced mutual fund. This fund strategically allocates capital across global public equity and debt markets, with a core investment objective of acquiring securities from companies within the healthcare sector. It also invests in various pooled investment vehicles. For its fixed income component, the fund holds corporate debt securities across the full spectrum of credit ratings. Established on April 2, 2014, and domiciled in the United States, its portfolio performance is measured against both the S&P 1500 Healthcare Index and the S&P 500 Index.

Comparable companies

Abrdn Healthcare Opportunities Fund is most often compared with the following Financial Services names:

BFTHXBFTIXDLYIENAXIGRJQCRMBKXROGSXSWOBXTHW
More research on THQ
THQ technical analysis THQ TheEdge Score Compare against peers
Open full interactive analysis & DCF →